The 2020 Interim report stated that all Directors of Renishaw have waived their rights to the 14.0 pence per share interim dividend which would result in a dividend payable of £4,782,067. The total dividend payable should have been stated as £5,124,377.
Allen Roberts FCA
Group Finance Director
27 February 2020
Renishaw plc
Registered office:
New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR
Registered number:
01106260, England and Wales
LEI number:
21380048ADXM6Z67CT18
Telephone:
+44 (0)1453 524524
Website:
www.renishaw.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
Renishaw plc published this content on 27 February 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 February 2020 16:53:08 UTC
Renishaw plc is a United Kingdom-based supplier of measuring systems and production systems. The principal activities of the Company are the design, manufacture, sale, distribution and service of manufacturing technologies products and services, and analytical instruments and medical devices. The Company operates through two segments: manufacturing technologies, and analytical instruments and medical devices. The manufacturing technologies segment consists of four areas: industrial metrology, additive manufacturing, position measurement and the new industrial automation line. The analytical instruments and medical devices segment consist of spectroscopy and neurological, where it supplies its customers with technologies to improve materials analysis and neurological therapies. Its products include CMM probes, software, and retrofits; equator gauging system; interferometric laser encoders; probing and tool measurement systems for machine tools, and others.
RENISHAW PLC 
